We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTKB icon
1676
Cytek Biosciences
CTKB
$546M
-37,884
Closed -$210K
CTO
1677
CTO Realty Growth
CTO
$815M
-11,711
Closed -$223K
CTRA
1678
DELISTED
Coterra Energy
CTRA
-13,639
Closed -$327K
CVCO icon
1679
Cavco Industries
CVCO
$4.55B
-3,404
Closed -$1.46M
CWAN
1680
DELISTED
Clearwater Analytics
CWAN
-18,582
Closed -$469K
CX icon
1681
Cemex
CX
$16.3B
-81,614
Closed -$498K
CZR icon
1682
Caesars Entertainment
CZR
$6.14B
-22,570
Closed -$942K
D icon
1683
Dominion Energy
D
$59.3B
-16,616
Closed -$960K
DAKT icon
1684
Daktronics
DAKT
$1.04B
-33,734
Closed -$436K
DAN icon
1685
Dana Inc
DAN
$3.06B
-55,378
Closed -$585K
DAR icon
1686
Darling Ingredients
DAR
$9.44B
-22,642
Closed -$841K
DAVA icon
1687
Endava
DAVA
$156M
-37,873
Closed -$967K
DCGO icon
1688
DocGo
DCGO
$62.6M
-445,805
Closed -$1.48M
DCI icon
1689
Donaldson
DCI
$11.4B
-17,282
Closed -$1.27M
DENN
1690
DELISTED
Denny's
DENN
-27,658
Closed -$178K
DFIN icon
1691
Donnelley Financial Solutions
DFIN
$1.16B
-10,376
Closed -$683K
DKS icon
1692
Dick's Sporting Goods
DKS
$18.7B
-2,011
Closed -$420K
DMLP icon
1693
Dorchester Minerals
DMLP
$1.26B
-18,521
Closed -$558K
DNA icon
1694
Ginkgo Bioworks
DNA
$521M
-120,169
Closed -$979K
DOC icon
1695
Healthpeak Properties
DOC
$14.8B
-78,094
Closed -$1.79M
DOCS icon
1696
Doximity
DOCS
$4.88B
-5,346
Closed -$233K
DORM icon
1697
Dorman Products
DORM
$4.18B
-7,099
Closed -$803K
DRRX
1698
DELISTED
DURECT Corp
DRRX
-41,790
Closed -$56K
DRS icon
1699
Leonardo DRS
DRS
$12B
-23,403
Closed -$660K
DT icon
1700
Dynatrace
DT
$14.2B
-7,092
Closed -$379K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.